Skip to main content

Day: July 5, 2024

Consolidated Water Sustains No Damage in Grand Cayman From Major Hurricane Beryl

GEORGE TOWN, Cayman Islands, July 05, 2024 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and operator of advanced water supply and treatment plants, reported that its property and equipment sustained no damage after Hurricane Beryl passed approximately 40 miles south of the Cayman Islands early Thursday morning. “Fortunately, Grand Cayman was spared the kind of damage that this storm caused to other islands in the Caribbean,” stated Consolidated Water CEO, Rick McTaggart. “There have been reports of flooding and wave damage to properties, particularly on the south side of Grand Cayman which is outside our retail water service area. Our dedicated and experienced operations staff ensured that we continued to supply water to our retail customers throughout the storm and I am...

Continue reading

Vantiva – June 2024 – Information concerning the total number of voting rights and shares

July 5, 2024 Vantiva: Information concerning the total number of voting rights and shares, provided pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés FinanciersVantiva Shares(ISIN Code FR0013505062)Date Number of Outstanding Shares Number of Voting RightsJune 30, 2024   490,145,266     Number of Theoretical Voting Rights(1): 490,145,266    Number of Voting Rights Exercisable at Shareholders’ meeting(2): 490,145,266  (1)    Calculated, pursuant to Article 223-11 of the General Regulations of the Autorité des Marchés Financiers, based on the total number of outstanding shares to which voting rights are attached, including shares with suspended voting rights. (2)    Excluding shares with suspended voting rights. *                ** About Vantiva www.vantiva.com...

Continue reading

Agillic receives approval of 71% of the applied tax credit and thereby concludes the full tax credit scheme review for 2019 – 2022. Net profit increases by DKK 10.5 million in 2024

Announcement no. 05 2024Contains insider information Copenhagen – 5 July 2024 – Agillic A/S Agillic has received a final decision from the Danish Tax Authorities regarding tax credit for the years 2019-2022 which approves the majority of the applied amount for all 4 years. The decision has the following financial impact in 2024: The income statement 2024 will be positively impacted by net interest DKK 1.7 million and tax income DKK 8.8 million resulting in a net profit increase of DKK 10.5 million. The decision will also increase the cash position by DKK 2.1 million, and reduce short term debt by DKK 8.4 million, while equity will increase by DKK 10.5 million. Subsequent to the Danish Tax Authorities (DTA) decision in 2023 to decline the entire tax credit for 2019, Agillic appealed the decision. In the annual report 2023, a full reservation...

Continue reading

MAX Power Launches USA Natural Hydrogen Strategic Alliance With Leading European Engineering Firm

Alliance Targets Natural Hydrogen Discoveries Across America VANCOUVER, British Columbia, July 05, 2024 (GLOBE NEWSWIRE) — MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) (“MAX Power” or the “Company”) is pleased to announce that it has entered into a Strategic Alliance with Larin Engineering HHC (“Larin”) of Prague, Czech Republic, a pioneering international engineering firm specializing in Natural Hydrogen, to target the first accumulations of Natural Hydrogen gas in the United States. Highlights:The Larin team, with offices in Europe and Dubai, has been conducting cutting-edge research into exploration and commercialization of Natural Hydrogen for 20 years and is now aggressively applying that expertise to the United States; Larin’s involvement in the recent successful first-ever drill program for Natural Hydrogen...

Continue reading

Combitech AS Becomes Part of Telenor Cyberdefence

(Fornebu, July 5, 2024): In June, Telenor established the cybersecurity company Telenor Cyberdefence. Now, Telenor Cyberdefence is acquiring Combitech AS (formerly Watchcom Security Group), which will become part of Telenor’s new cybersecurity company. The acquisition strengthens Telenor Cyberdefence’s position as a leading provider of cybersecurity solutions to private and public businesses in Norway, with the ambition to expand across the Nordics. The purchase price is confidential between the parties. “When we announced Telenor Cyberdefence, we stated that we have big ambitions. This acquisition demonstrates that, and we have more in the pipeline,” says Dan Ouchterlony, Head of Telenor Amp. Telenor Cyberdefence is part of the Telenor Amp portfolio, which consists of 15 wholly or partially owned companies with...

Continue reading

ALSTOM SA: Alstom Note – Q1 2024/25 Preview

Alstom Note – Q1 2024/25 Preview 5 July 2024 – Alstom presents below a preview to its Q1 2024/25 orders and sales results. Q1 2024/25 Orders The table below summarizes the large orders (more than €200 million) published and booked during the quarter.Orders   Value(in € million) Description Link to press releaseUndisclosed customer ~400 12 years Services order in AMECA region LinkPolo Logistica FS 323 70 TRAXX locomotives LinkUndisclosed customer 670 Rolling stock and signaling for a European customer LinkElizabeth line 430 10 trains for Elizabeth Line in UK + maintenance LinkTotal large orders ~1,823    Deals announced previously, but to be booked at a later stageHaifa-Nazareth Systems contract for ~€700 million, expected booking in FY 2025/26: link to the press...

Continue reading

FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss

Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness Designed to simplify administration, Vabysmo PFS provides retina specialists a ready-to-use option Vabysmo PFS will be available for people living with nAMD, DME and RVOBasel, 05 July 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the United States Food and Drug Administration (US FDA) has approved the Vabysmo® (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of neovascular or ‘wet’ age-related macular degeneration (nAMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion (RVO). Together, these three conditions affect close to 80 million people globally.1-4 The Vabysmo PFS will become available to United States...

Continue reading

Unifiedpost Group continues its strategic focus on growing core digital services with the divestment of 21 Grams

Press Release – Inside Information La Hulpe, Belgium – 5 July 2024, 7:00 am. CET – Inside Information – Unifiedpost Group SA (Euronext Brussels: UPG) (Unifiedpost, Group), a leading provider of integrated business communications, today announced it has signed an agreement with PostNord Strålfors AB (“PostNord Strålfors”) for the sale of all shares in the 21 Grams Group (“21 Grams”) for a purchase price based on an enterprise value (on a cash and debt-free basis) of SEK 200 million, subject to certain potential adjustments based on the financial position of 21 Grams at completion of the sale. The agreement also includes an exclusive partnership to distribute Banqup and B2B digital products to PostNord Strålfors’ customer network. [INSIDE INFORMATION] Key highlightsThe sale aligns with Unifiedpost’s continued strategic focus...

Continue reading

Medsenic, subsidiary of BioSenic SA, extends key patent to the United States

PRESS RELEASE – PRIVILEGED INFORMATION The developed Medsenic’s composition-of-matter patent family does cover the therapeutic use of arsenic salts and metal ions through various routes of administration.Medsenic’s enriched IP portfolio is aimed at protecting medications involving the combination of arsenic trioxide (ATO) and copper ions, which have demonstrated increased therapeutic potential for indications ranging from immune to cancer and to infectious diseases.Mont-Saint-Guibert, Belgium, July 5, 2024, 7.00am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell repair therapy, today announces the filing of the continuation patent application US 18/763,376 with the United States Patent & Trademark Office (USPTO) to provide protection...

Continue reading

Lerøy Seafood Group ASA: Trading update Q2 2024

  HARVEST VOLUMES OF SALMON AND TROUT Total harvest volume of salmon and trout for Q2 2024 was 36,700 GWT, excluding volumes from Scottish Seafarms. Harvest volumes per region/company (in 1,000 GWT): Lerøy Aurora: 5.1 Lerøy Midt: 15.7 Lerøy Sjøtroll: 15.9 (of which 5.3 was trout) CATCH VOLUMES OF WILDFISH Total wild catch volumes (Lerøy Havfisk) was 17,800 tonnes for Q2 2024 of which 1,500 tonnes of cod. The complete Q2 2024 report will be released on 21 August 2024 at 06:30 CET. Queries may be addressed to the company’s CFO Sjur S. Malm. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.  

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.